Detalhe da pesquisa
1.
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
Gynecol Oncol
; 154(1): 95-101, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118140
2.
Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8+ T cells compared with women with BRCA wild-type disease during the early disease course.
Oncol Lett
; 18(4): 3914-3924, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31516602